VN August 2021
Vetnews | August 2021 39 Topical ophthalmic atropine in horses This pilot study by Augustin Lenoir and co-workers in France compared the use of a UV-polymerisablemethacrylate adhesive (UV-PMA) versus an inverting pattern as the second layer of a two-layer hand-sewn jejunal anastomosis in horses. Resection and anastomosis of small intestine during colic can lead to adhesions and recurrent colic. Several methods are available to reduce the rate of adhesions in the post- operative period, such as the use of serosal barriers. Surgical glues forma smooth surface, are fast to apply, and could reduce surgery time when performing anastomosis. A recently developed UV-PMA is designed to anchor into the biological tissues’ top surface offering sealant and a smooth cover over the anastomosis site. This adhesive was used ex vivo on 15 samples of equine jejunum as the second layer of a two-layer anastomosis (1L-UV-PMAgroup) and compared to a two- layer anastomosis (simple continuous pattern coveredwithaCushing pattern; 2L-CT group), in terms of feasibility, bursting strength pressure (BSP), luminal diameter reduction (LDR), and time of construction. Data were analysed using a paired t-test or a chi-square test. The results showed no statistical difference in BSP, LDR, or anymode of failure between the two anastomosis types. However, the glue anastomosis formed a tunnel-like anastomosis and shredded under pressure, before apparition of leakage, preventing its usage in clinical cases with this methodology. The authors concluded that modification of the technique is warranted before testing in clinical cases. v Use of adhesive for anastomosis This study by Lena Ström and co-workers in Sweden, France and the UK investigated the administration of topical ophthalmic atropine in horses, including the pharmacokinetics and effect on intestinal motility. Topical ophthalmic atropine sulfate is an important part of the treatment protocol in equine uveitis. Frequent administration of topical atropine may cause decreased intestinal motility and colic in horses due to systemic exposure. Little is known on atropine pharmacokinetics in horses and this knowledge gap could impede the use of atropine because of the presumed risk of unwanted effects. Additional information could therefore increase safety in atropine treatment. Atropine sulfate (1 mg) was administered in two experiments: In part I, atropine sulfate was administered intravenously and topically (manually as eye drops and through a subpalpebral lavage system) to six horses to document atropine disposition. Blood-samples were collected regularly and plasma was analysed for atropine using UHPLC- MS/MS. Atropine plasma concentration was below lower limit of quantification (0.05 μg/L) within 5 h, after both topical and i.v. administration. Atropine data were analysed using population compartmental modelling and pharmacokinetic parameters estimated.The typical valuewas 1.7 L/kg for the steady-state volumeof distribution. Total plasma clearance was 1.9 L/h/kg. The bioavailability after administration of an ophthalmic preparation as an eye drop or topical infusion were 69% and 68%, respectively. The terminal half- life was short (0.8 h). In part II, topical ophthalmic atropine sulfate and control treatment was administered to four horses in two dosing regimens to assess the effect on gastrointestinal motility. Borborygmi- frequency monitored by auscultation was used for estimation of gut motility. A statistically significant decrease in intestinal motility was observed after administration of 1 mg topical ophthalmic atropine sulfate every 3 h compared to control, but not after administration every 6 h. Clinical signs of colic were not observed under any of the treatment protocols. Taking the plasma exposure after topical administration into consideration, data and simulations indicate that eye drops administered at 1 and 3 h intervals will lead to atropine accumulation in plasma over 24 h. A 6 h interval allows total washout of atropine between two topical administrations. If constant corneal and conjunctival atropine exposure is required, a topical constant rate infusion at 5 μg/kg/24 h offers a safe alternative. v ( Equine Veterinary Education , July 2021) Recent Clinically Relevant Research from Around theWorld Animal Ethics andWelfare Animal Ethics andWelfare The SAVC recently circulated an article: Pain Management in Farm Animals: Focus on Cattle, Sheep and Pigs (Steagall et al. , 2021). This topic requires open discussion about pain recognition and control by farmers and vets to ensure that scheduled drugs remain under veterinary control in South Africa. Article summary: Thearticle clarifies thephysiologyof painand theeffects of perceived pain on the welfare of animals. It discusses more recent pain scoring systems as well as the advantages of newer farming methods and technologies. Food animal welfare – Pain management during routine farming procedures >>> 40
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=